[ad_1]
The World Health Organization has added the Sinopharm vaccine to its list of approved Covid-19 owners, which has bolstered China’s dose certifications amid doubts about its effectiveness.
Tedros Adhanom Ghebreyesus, Director-General of the WHO, said Tedros Adhanom Ghebreyesus, Director-General of the WHO, developed emergency use of the shot in collaboration with the Beijing Institute of Biological Products for two-dose regimens for all adults over 18 years of age.
It is the first vaccine of all kinds in China to be approved for use in WHO emergencies. Acceptance is a sign for countries Sinopharm vaccine It is safe to use and will be added to the WHO’s Covax vaccine program.
Alejandro Cravioto, chairman of the WHO’s strategic group of experts on vaccines, said the panel had conducted an “in-depth assessment” of the vaccine, and that “sufficient evidence” was safe and reduced cases of serious or symptomatic disease. at least 79 percent.
Initial research on the vaccine was conducted mainly in China, where coronaviruses are already stored there. In the final phase or phase 3, the studies were conducted in other countries. Sinopharm has a second two-dose coronavirus vaccine, developed by Wuhan with the Institute of Biological Products, which has not yet been approved by the WHO.
The WHO’s approval is a victory for Sinopharm, which is China’s largest producer of vaccines for the domestic market and supplies most suppliers to the state’s vaccine programs but has not yet established itself as a vaccine exporter.
The company did not immediately respond to the request for comment.
China has been committed to the Covid vaccine around the developing world, but international expansion has been hampered by concerns about its effectiveness, as Chinese manufacturers have been slower than Western candidates to publish accurate test data.
The WHO noted the lack of relativity in the data of elderly patients, and recommended that surveillance studies be conducted in countries where older people are shot.
Acceptance of the bases means that Covid can be used in countries with devastating waves, such as India and Brazil, the WHO said.
Mohga Kamal-Yanni, a health policy expert for the People’s Vaccine Alliance, said the recognition is “great news” for people in developing countries as they watch people from rich countries take the vaccine for months. line “.
Mariângela Simão, the WHO’s assistant director-general for access to medicines, said the admission has the potential to “speed up” access to countries that want to protect health workers and people at risk.
[ad_2]
Source link
